Selected publications

Vermeiren P., Aubert V., Sugamele R., Aubert J.D., Venetz J.P., Meylan P., Pascual M., Manuel O., Influenza vaccination and humoral alloimmunity in solid organ transplant recipients.Transplant International 2014, in press

Tissot F., Pascual M., Hullin R., Yerly P., Tozzi P., Meylan P., Manuel O., Impact of targeted antifungal prophylaxis in heart transplant recipients at high risk for early invasive fungal infection. Transplantation 2014, 15:1192-97

Manuel O., Kralidis G., Mueller N.J., Hirsch H.H., Garzoni C., van Delden C., Berger C., Boggian K., Cusini A., Koller M.T., Weisser M., Pascual M., Meylan P.R., Swiss Transplant Cohort Study. Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients. American Journal of Transplantation 2013, 13:2402-10

Manuel O., Estabrook M., AST Infectious Dieases Community of Practice. RNA respiratory viruses in solid organ transplantation. American Journal of Transplantation 2013, Suppl 13:4:212-9

Manuel O., Husain S., Kumar D., et al,Assessment of cytomegalovirus specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study. Clinical Infectious Diseases 2013, 56:817-824

Manuel O., Pascual M., Hoschler K., Giulieri S., Alves D., Ellefsen K., Bart P.A., Venetz J.P., Calandra T., Cavassini M., Humoral Response to the Influenza A H1N1/09 Monovalent AS03-Adjuvanted Vaccine in Immunocompromised Patients. Clinical Infectious Diseases 2011, 52:248-256.

Boillat Blanco N., Pascual M., Venetz J.P., Nseir G., Meylan P.R., Manuel O., Impact of a preemptive strategy after 3 months of valganciclovir cytomegalovirus prophylaxis in kidney transplant recipients. Transplantation 2011,9:251-255.


 Last updated on 18/06/2018 at 20:00